Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Adjuvant capecitabine did not significantly improve outcomes for breast cancer...

Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for...

Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )

Two clinical trials using combination therapy in adult patients with multiple...

Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA

Two clinical trials using combination therapy in adult patients with multiple myeloma ( Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA )

Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients

Professors Hope Rugo, Debu Tripathy, Nadia Harbeck and Dr Steven Isakoff

Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients ( Professors Hope Rugo, Debu Tripathy, Nadia Harbeck and Dr Steven Isakoff )

Role of chemotherapy in the treatment of metastatic breast cancer patients

Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani

Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018

Professor Chris Twelves and Dr Giampaolo Bianchini

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018 ( Professor Chris Twelves and Dr Giampaolo Bianchini )

The combined analysis of carfilzomib trials for multiple myeloma

Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain

The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )

KRd versus VRd in patients with newly diagnosed multiple myeloma

Dr Ola Landgren - Memorial Sloan Kettering Cancer Centre, New York, USA

KRd versus VRd in patients with newly diagnosed multiple myeloma ( Dr Ola Landgren - Memorial Sloan Kettering Cancer Centre, New York, USA )

Researchers identify mutation that causes resistance to venetoclax in CLL...

Dr Piers Blombery - University of Melbourne, Melbourne, Australia

Researchers identify mutation that causes resistance to venetoclax in CLL patients ( Dr Piers Blombery - University of Melbourne, Melbourne, Australia )

Daratumumab increases PFS in patients with transplant-ineligible multiple...

Prof Thierry Facon - Hôpital Claude Huriez, Lille, France

Daratumumab increases PFS in patients with transplant-ineligible multiple myeloma ( Prof Thierry Facon - Hôpital Claude Huriez, Lille, France )

Ibrutinib and rituximab provides superior PFS and OS compared to FCR for...

Dr Tait Shanafelt - Standford University, Stanford, USA

Ibrutinib and rituximab provides superior PFS and OS compared to FCR for younger patients with previously untreated CLL ( Dr Tait Shanafelt - Standford University, Stanford, USA )

Resistance mechanisms to venetoclax in patients with progressive CLL

Dr Piers Blombery - University of Melbourne, Melbourne, Australia

Resistance mechanisms to venetoclax in patients with progressive CLL ( Dr Piers Blombery - University of Melbourne, Melbourne, Australia )

More from ecancer